Dyne Therapeutics, Inc.

NASDAQ:DYN

Biotechnology

Healthcare
$16.03 +1.97%

+$0.38 today

Market cap
$3.00B
Beta
1.08
P/E (TTM)
-7.2
EPS (TTM)
-$2.74
52W Low $8.06High $25.00

Volume 2.44M

Average 1.71M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.19B

FY 2025 · Annual

+71.7% YoY

Liabilities

$214.83M

FY 2025 · Annual

+249.9% YoY

Equity

$972.13M

FY 2025 · Annual

+54.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents200.83M172.15M121.63M435.45M893.37M
Short-term Investments175.75M83.87M1.47M206.82M217.19M
Net Receivables00000
Inventory00000
Other Current Assets383K9.58M6.28M17.01M16.03M
Total Current Assets382.39M265.59M129.38M659.28M1.13B
Property, Plant & Equipment (Net)40.96M38.41M33.39M30.01M44.77M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets2.31M2.32M2.32M1.94M15.6M
Total Non-current Assets43.27M40.73M35.71M31.96M60.37M
Total Assets425.66M306.33M165.08M691.23M1.19B
Account Payables4.03M5.26M22.94M6.56M8.08M
Short-term Debt0004.85M5M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00017.75M37.55M
Total Current Liabilities28.72M28.09M51.1M42.26M50.63M
Long-term Debt000015.28M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000148.92M
Total Non-current Liabilities28.74M25.87M22.7M19.14M164.2M
Total Liabilities57.47M53.96M73.79M61.4M214.83M
Common Stock6K6K6K10K16K
Retained Earnings(228.47M)(396.57M)(632.51M)(949.93M)(1.4B)
Accumulated OCI(269K)(571K)06K475K
Other Stockholders Equity00000
Minority Interest00000
Total Equity368.2M252.36M91.29M629.84M972.13M
Total Debt32.64M30.48M27.42M23.99M20.28M
Net Debt(168.19M)(141.66M)(94.21M)(411.46M)(873.09M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$676.1M
Short-term Investments$222.4M
Other Current$39.4M
Total Current Assets$937.9M
PP&E (Net)$44.8M
Other Non-current$11.3M
Total Non-current Assets$56.1M
Total Assets$994.0M

Analysis

Selected assets total $994.0M for Latest. The largest visible component is Cash & Equivalents at $676.1M, about 68.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 22, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportSep 29, 2026

How much cash does DYN have?

Dyne Therapeutics, Inc. (DYN) reported $893.37M in cash and equivalents in fiscal 2025.

How much debt does DYN carry?

Dyne Therapeutics, Inc. (DYN) reported $20.28M of total debt, with net debt of -$873.09M.